Neil F. McFarlane's Net Worth

$2.68 Million

Estimate Recalculated Nov 1, 2024 09:17AM EST

Who is Neil F. McFarlane

Neil F. McFarlane has an estimated net worth of $2.68 Million. This is based on reported shares across multiple companies, which include ZEVRA THERAPEUTICS, INC., Retrophin, Inc., COLLEGIUM PHARMACEUTICAL, INC, and Adamas Pharmaceuticals Inc.

SEC CIK

Neil F. McFarlane's CIK is 0001681098

Past Insider Trading and Trends

2018 was Neil F. McFarlane's most active year for acquiring shares with 6 total transactions. Neil F. McFarlane's most active month to acquire stocks was the month of April. 2018 was Neil F. McFarlane's most active year for disposing of shares, totalling 4 transactions. Neil F. McFarlane's most active month to dispose stocks was the month of October. 2024 saw Neil F. McFarlane paying a total of $0.00 for 707,693 shares, this is the most they've acquired in one year. In 2018 Neil F. McFarlane cashed out on 21,125 shares for a total of $485,647.59, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ZEVRA THERAPEUTICS, INC.

President and CEO
Updated Feb 02, 2024
Form 4
700.00K
Feb 02, 2024
700.00K
Grant
Jan 31
Form 4
800.00K
Oct 11, 2023
800.00K
Grant
Oct 10
Form 3
Oct 10, 2023
Showing 3 results

Retrophin, Inc.

Chief Operating Officer
Updated May 16, 2019
Form 4
-6.80%
-1.97K
$18.25
-$35.91K
May 16, 2019
26.99K
Sale
ScheduledMay 15 - May 16
Form 4
-27.76%
-11.13K
$22.32
-$248.33K
Dec 21, 2018
28.96K
Sale
ScheduledDec 20
Form 4
38.42%
11.13K
Dec 20, 2018
40.08K
Grant
Dec 18
Form 4
-25.99%
-10.00K
$23.73
-$237.31K
Nov 16, 2018
28.48K
Sale
ScheduledNov 14
Form 4
35.12%
10.00K
Nov 14, 2018
38.48K
Grant
Nov 09
Form 4
481.43%
84.00K
May 14, 2018
101.45K
Grant
May 10
Form 4
17.08%
2.55K
Feb 12, 2018
17.45K
Grant
Feb 08
Form 4
-9.19%
-1.38K
$22.50
-$31.00K
Aug 17, 2017
13.62K
Sale
Aug 16
Form 4
90.00K
May 18, 2017
90.00K
Grant
May 17
Form 4
135.00K
Aug 15, 2016
135.00K
Grant
Aug 15
Form 3
Aug 15, 2016
Showing 11 results

COLLEGIUM PHARMACEUTICAL, INC

Investor
Updated May 16, 2024
Form 4
18.46%
7.69K
May 16, 2024
49.37K
Grant
May 16
Form 4
30.72%
9.79K
May 19, 2023
41.67K
Grant
May 18
Form 4
78.65%
14.04K
May 23, 2022
31.88K
Grant
May 19
Form 4
17.84K
Apr 08, 2022
17.85K
Grant
Apr 06
Form 3
Apr 08, 2022
Showing 5 results

Adamas Pharmaceuticals Inc

Chief Executive Officer
Updated Nov 24, 2021
Form 4
-100.00%
-975.00K
Nov 24, 2021
Disposition
Nov 24
Form 4
133.33%
300.00K
Mar 03, 2021
525.00K
Grant
Mar 02
Form 4
240.00%
300.00K
Mar 20, 2020
425.00K
Grant
Mar 18
Form 4
375.00K
Sep 17, 2019
375.00K
Grant
Sep 16
Form 3
Sep 17, 2019
Showing 5 results